Brinda Balakrishnan/LinkedIn
Dec 22, 2025, 12:39
Shining a Light on von Willebrand Disease: An Often Overlooked Bleeding Disorder
Brinda Balakrishnan, Board Member of Aurinia Pharmaceuticals Inc., shared a post by Star Therapeutics on LinkedIn:
“There continue to be many sizable, rare disorders with few to no therapeutic options. Glad that Star is shining a light on VWD and developing novel medicines to address patient needs!”
Quoting Star Therapeutics‘ post:
“von Willebrand Disease is often overlooked compared to other bleeding disorders like hemophilia, leaving many patients without the resources and support they deserve.
Listen as Nick shares his experience growing up with a condition that was frequently misunderstood and the impact that has had on his journey with VWD.”

Find more related posts on Hemostasis Today.
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session
-
Aug 30, 2026, 17:02David McGlasson: A 2020 Article Reaches 8,000 Reads
-
Aug 30, 2026, 16:18Tushar Namdeo: Platelets in Different Diseases